New developments in the treatment of partial-onset epilepsy

por Besag, Frank MC, Patsalos, Philip N
Publicado 2012

Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures

por Besag, Frank MC, Patsalos, Philip N
Publicado 2016

Perampanel: What is its Place in the Management of Partial Onset Epilepsy?

por Ledingham, David R. M., Patsalos, Philip N.
Publicado 2013

Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs

por Patsalos, Philip N., Szaflarski, Jerzy P., Gidal, Barry, VanLandingham, Kevan, Critchley, David, Morrison, Gilmour
Publicado 2020

Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospectiv...

por Borghs, Simon, Byram, Laura, Chan, Jane, Dedeken, Peter, Logan, John, Kiri, Victor, Noack-Rink, Matthias, Patsalos, Philip N., Thieffry, Solène
Publicado 2020

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force

por Niyongere, Jenna, Welty, Timothy E., Bell, Michelle W., Consalvo, Damian, Hammond, Charles, Leung, Howan, Patsalos, Philip N., Ryan, Melody, Suansanae, Thanarat, Zhou, Dong, Zuellig, Hazel
Publicado 2022